171 related articles for article (PubMed ID: 10516550)
21. The safety of blood components and derivatives.
Julius C; Westphal RG
Hematol Oncol Clin North Am; 1992 Oct; 6(5):1057-77. PubMed ID: 1400072
[TBL] [Abstract][Full Text] [Related]
22. The risks of transfusion-transmitted infection: direct estimation and mathematical modelling.
Kleinman SH; Busch MP
Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):631-49. PubMed ID: 11102281
[TBL] [Abstract][Full Text] [Related]
23. Surveillance of transfusion-transmissible infections comparison of systems in five developed countries.
O'Brien SF; Zou S; Laperche S; Brant LJ; Seed CR; Kleinman SH
Transfus Med Rev; 2012 Jan; 26(1):38-57. PubMed ID: 21944935
[TBL] [Abstract][Full Text] [Related]
24. Long-awaited Canadian blood report released.
Murray T
Nat Med; 1998 Jan; 4(1):10. PubMed ID: 9427591
[No Abstract] [Full Text] [Related]
25. [Transfusion safety, time for a new partnership between stake-holders].
Erard AC; Garnerin P; Michel M; Peyrard T; Clergue F
Rev Med Suisse; 2006 Nov; 2(88):2680-3. PubMed ID: 17265807
[TBL] [Abstract][Full Text] [Related]
26. Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule.
Fed Regist; 1996 Sep; 61(175):47413-23. PubMed ID: 10160337
[TBL] [Abstract][Full Text] [Related]
27. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
28. Blood & politics.
Titus K
CAP Today; 1996 Mar; 10(3):20, 22-4. PubMed ID: 10160264
[No Abstract] [Full Text] [Related]
29. Safety improving by complementary serological and molecular testing combined with pathogen reduction of the donated blood in window period.
Balint B; Vucetic D; Todorovic-Balint M; Borovcanin N; Jovanovic-Cupic S; Mandusic V
Transfus Apher Sci; 2013 Aug; 49(1):103-4. PubMed ID: 23820432
[No Abstract] [Full Text] [Related]
30. Advances in pretransfusion infectious disease testing: ensuring the safety of transfusion therapy.
Downes KA; Yomtovian R
Clin Lab Med; 2002 Jun; 22(2):475-90. PubMed ID: 12134472
[TBL] [Abstract][Full Text] [Related]
31. Progress Toward Strengthening National Blood Transfusion Services - 14 Countries, 2011-2014.
Chevalier MS; Kuehnert M; Basavaraju SV; Bjork A; Pitman JP
MMWR Morb Mortal Wkly Rep; 2016 Feb; 65(5):115-9. PubMed ID: 26866413
[TBL] [Abstract][Full Text] [Related]
32. Transfusion medicine issues in the practice of anesthesiology.
Robblee JA; Crosby E
Transfus Med Rev; 1995 Jan; 9(1):60-78. PubMed ID: 7719039
[No Abstract] [Full Text] [Related]
33. Recruitment and management of donors. A perspective from the United States.
Sandler SG
Vox Sang; 1994; 67 Suppl 3():137-8. PubMed ID: 7975478
[No Abstract] [Full Text] [Related]
34. Romanian blood donors screening: is it really necessary and/or mandatory?
Hâţu G; Brumboiu MI; Gorgan IN; Bocşan IS
Rev Med Chir Soc Med Nat Iasi; 2013; 117(3):741-6. PubMed ID: 24502043
[TBL] [Abstract][Full Text] [Related]
35. Blood transfusion practice in a rural hospital in Northern Ghana, Damongo, West Gonja District.
Kubio C; Tierney G; Quaye T; Nabilisi JW; Ziemah C; Zagbeeb SM; Shaw S; Murphy WG
Transfusion; 2012 Oct; 52(10):2161-6. PubMed ID: 22612858
[TBL] [Abstract][Full Text] [Related]
36. The development of West Nile virus safety policies by Canadian blood services: guiding principles and a comparison between Canada and the United States.
Vamvakas EC; Kleinman S; Hume H; Sher GD
Transfus Med Rev; 2006 Apr; 20(2):97-109. PubMed ID: 16565024
[TBL] [Abstract][Full Text] [Related]
37. Donation archives and prospective donor-recipient repositories: indispensable tools for monitoring blood safety.
Allain JP; Busch MP
Transfusion; 2007 Jul; 47(7):1110-4. PubMed ID: 17581143
[No Abstract] [Full Text] [Related]
38. Progress toward strengthening blood transfusion services--14 countries, 2003-2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(47):1273-7. PubMed ID: 19037194
[TBL] [Abstract][Full Text] [Related]
39. The Dublin Consensus Statement on vital issues relating to the collection of blood and plasma and the manufacture of plasma products. PLUS.
Mahony BO; Turner A
Vox Sang; 2010 Apr; 98(3 Pt 2):447-50. PubMed ID: 20158697
[No Abstract] [Full Text] [Related]
40. Estimated risk of HIV transmission by blood transfusion in Kenya.
Moore A; Herrera G; Nyamongo J; Lackritz E; Granade T; Nahlen B; Oloo A; Opondo G; Muga R; Janssen R
Lancet; 2001 Aug; 358(9282):657-60. PubMed ID: 11530174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
